A

Acumen Pharmaceuticals

ABOS

3.22500
USD
-0.065
(-1.98%)
مغلق
حجم التداول
2,577
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
173,330,160
الأخبار المقالات

العنوان: Acumen Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers.